relatlimab,nivolumab,ipilimumab
bms
['melanoma', 'melsm', 'relativity-047', 'check,mate,067']
updated checkmate-067 and relativity-047 data on 1l io combinations reinforce their value in metastatic #melanoma #asco22 #ascodailynews #melsm
Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ? endorse.